Role of tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and associated proteins in coronary artery disease and cardiac events

Melody El Chemaly, V. E. McGilligan, Mark Gibson, Matthias Clauss, Steven Watterson, H. Denis Alexander, AJ Bjourson, Aaron Peace

Research output: Contribution to journalArticle

Abstract

Summary Tumour necrosis factor alpha converting enzyme (TACE/ADAM17) is a member of the A disintegrin and metalloproteinase (ADAM) family of ectodomain shedding proteinases. It regulates many inflammatory processes by cleaving several transmembrane proteins, including tumour necrosis factor alpha (TNFalpha) and its receptors tumour necrosis factor alpha receptor 1 and tumour necrosis factor alpha receptor 2. There is evidence that TACE is involved in several TACE inflammatory diseases, such as ischaemia, heart failure, arthritis, atherosclerosis, diabetes and cancer as well as neurological and immune diseases. This review summarizes the latest discoveries regarding the mechanism of action and regulation of TACE. It also focuses on the role of TACE in atherosclerosis and coronary artery disease (CAD), highlighting clinical studies that have investigated its expression and protein activity. The multitude of substrates cleaved by TACE make this enzyme an attractive target for therapy and a candidate for biomarker research and development in CAD.
LanguageEnglish
Article numberACVD-1047
Pages700-711
Number of pages12
JournalArchives of Cardiovascular Diseases
Volume110
Issue number12
Early online date31 Oct 2017
DOIs
Publication statusE-pub ahead of print - 31 Oct 2017

Fingerprint

Coronary Artery Disease
Tumor Necrosis Factor-alpha
Atherosclerosis
Receptors, Tumor Necrosis Factor, Type II
Disintegrins
Tumor Necrosis Factor Receptors
Immune System Diseases
Metalloproteases
Arthritis
Proteins
Peptide Hydrolases
Ischemia
Heart Failure
Biomarkers
Research
ADAM17 Protein
Neoplasms
Therapeutics
Clinical Studies

Keywords

  • Atherosclerosis, Transmembrane proteins, TNFα, Biomarker, TACE

Cite this

@article{daa1ab1db5b243319660f4c45a87e2d8,
title = "Role of tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and associated proteins in coronary artery disease and cardiac events",
abstract = "Summary Tumour necrosis factor alpha converting enzyme (TACE/ADAM17) is a member of the A disintegrin and metalloproteinase (ADAM) family of ectodomain shedding proteinases. It regulates many inflammatory processes by cleaving several transmembrane proteins, including tumour necrosis factor alpha (TNFalpha) and its receptors tumour necrosis factor alpha receptor 1 and tumour necrosis factor alpha receptor 2. There is evidence that TACE is involved in several TACE inflammatory diseases, such as ischaemia, heart failure, arthritis, atherosclerosis, diabetes and cancer as well as neurological and immune diseases. This review summarizes the latest discoveries regarding the mechanism of action and regulation of TACE. It also focuses on the role of TACE in atherosclerosis and coronary artery disease (CAD), highlighting clinical studies that have investigated its expression and protein activity. The multitude of substrates cleaved by TACE make this enzyme an attractive target for therapy and a candidate for biomarker research and development in CAD.",
keywords = "Atherosclerosis, Transmembrane proteins, TNFα, Biomarker, TACE",
author = "{El Chemaly}, Melody and McGilligan, {V. E.} and Mark Gibson and Matthias Clauss and Steven Watterson and Alexander, {H. Denis} and AJ Bjourson and Aaron Peace",
year = "2017",
month = "10",
day = "31",
doi = "10.1016/j.acvd.2017.08.002",
language = "English",
volume = "110",
pages = "700--711",
number = "12",

}

Role of tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and associated proteins in coronary artery disease and cardiac events. / El Chemaly, Melody; McGilligan, V. E.; Gibson, Mark; Clauss, Matthias ; Watterson, Steven; Alexander, H. Denis; Bjourson, AJ; Peace, Aaron.

Vol. 110, No. 12, ACVD-1047, 31.10.2017, p. 700-711.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Role of tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and associated proteins in coronary artery disease and cardiac events

AU - El Chemaly, Melody

AU - McGilligan, V. E.

AU - Gibson, Mark

AU - Clauss, Matthias

AU - Watterson, Steven

AU - Alexander, H. Denis

AU - Bjourson, AJ

AU - Peace, Aaron

PY - 2017/10/31

Y1 - 2017/10/31

N2 - Summary Tumour necrosis factor alpha converting enzyme (TACE/ADAM17) is a member of the A disintegrin and metalloproteinase (ADAM) family of ectodomain shedding proteinases. It regulates many inflammatory processes by cleaving several transmembrane proteins, including tumour necrosis factor alpha (TNFalpha) and its receptors tumour necrosis factor alpha receptor 1 and tumour necrosis factor alpha receptor 2. There is evidence that TACE is involved in several TACE inflammatory diseases, such as ischaemia, heart failure, arthritis, atherosclerosis, diabetes and cancer as well as neurological and immune diseases. This review summarizes the latest discoveries regarding the mechanism of action and regulation of TACE. It also focuses on the role of TACE in atherosclerosis and coronary artery disease (CAD), highlighting clinical studies that have investigated its expression and protein activity. The multitude of substrates cleaved by TACE make this enzyme an attractive target for therapy and a candidate for biomarker research and development in CAD.

AB - Summary Tumour necrosis factor alpha converting enzyme (TACE/ADAM17) is a member of the A disintegrin and metalloproteinase (ADAM) family of ectodomain shedding proteinases. It regulates many inflammatory processes by cleaving several transmembrane proteins, including tumour necrosis factor alpha (TNFalpha) and its receptors tumour necrosis factor alpha receptor 1 and tumour necrosis factor alpha receptor 2. There is evidence that TACE is involved in several TACE inflammatory diseases, such as ischaemia, heart failure, arthritis, atherosclerosis, diabetes and cancer as well as neurological and immune diseases. This review summarizes the latest discoveries regarding the mechanism of action and regulation of TACE. It also focuses on the role of TACE in atherosclerosis and coronary artery disease (CAD), highlighting clinical studies that have investigated its expression and protein activity. The multitude of substrates cleaved by TACE make this enzyme an attractive target for therapy and a candidate for biomarker research and development in CAD.

KW - Atherosclerosis, Transmembrane proteins, TNFα, Biomarker, TACE

U2 - 10.1016/j.acvd.2017.08.002

DO - 10.1016/j.acvd.2017.08.002

M3 - Article

VL - 110

SP - 700

EP - 711

IS - 12

M1 - ACVD-1047

ER -